Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Endocrine-Disrupting Chemicals and Disease Endpoints

View through CrossRef
Endocrine-disrupting chemicals (EDCs) have significant impacts on biological systems, and have been shown to interfere with physiological systems, especially by disrupting the hormone balance. During the last few decades, EDCs have been shown to affect reproductive, neurological, and metabolic development and function and even stimulate tumor growth. EDC exposure during development can disrupt normal development patterns and alter susceptibility to disease. Many chemicals have endocrine-disrupting properties, including bisphenol A, organochlorines, polybrominated flame retardants, alkylphenols, and phthalates. These compounds have gradually been elucidated as risk factors for many diseases, such as reproductive, neural, and metabolic diseases and cancers. Endocrine disruption has been spread to wildlife and species that are connected to the food chains. Dietary uptake represents an important source of EDC exposure. Although EDCs represent a significant public health concern, the relationship and specific mechanism between EDCs and diseases remain unclear. This review focuses on the disease-EDC relationship and the disease endpoints associated with endocrine disruption for a better understanding of the relationship between EDCs-disease and elucidates the development of new prevention/treatment opportunities and screening methods.
Title: Endocrine-Disrupting Chemicals and Disease Endpoints
Description:
Endocrine-disrupting chemicals (EDCs) have significant impacts on biological systems, and have been shown to interfere with physiological systems, especially by disrupting the hormone balance.
During the last few decades, EDCs have been shown to affect reproductive, neurological, and metabolic development and function and even stimulate tumor growth.
EDC exposure during development can disrupt normal development patterns and alter susceptibility to disease.
Many chemicals have endocrine-disrupting properties, including bisphenol A, organochlorines, polybrominated flame retardants, alkylphenols, and phthalates.
These compounds have gradually been elucidated as risk factors for many diseases, such as reproductive, neural, and metabolic diseases and cancers.
Endocrine disruption has been spread to wildlife and species that are connected to the food chains.
Dietary uptake represents an important source of EDC exposure.
Although EDCs represent a significant public health concern, the relationship and specific mechanism between EDCs and diseases remain unclear.
This review focuses on the disease-EDC relationship and the disease endpoints associated with endocrine disruption for a better understanding of the relationship between EDCs-disease and elucidates the development of new prevention/treatment opportunities and screening methods.

Related Results

Endocrine Disrupting Chemicals and the Effects They Play in Plant Regulators
Endocrine Disrupting Chemicals and the Effects They Play in Plant Regulators
Over the past few decades, there has been increased global concern regarding Endocrine Disrupting Chemicals (EDCs). Endocrine disrupting chemicals, also known as Endocrine Disrupto...
Linking of chemical and effect-based monitoring to support comprehensive assessment of pollution in wastewater and surface water
Linking of chemical and effect-based monitoring to support comprehensive assessment of pollution in wastewater and surface water
Since the beginning of industrialisation, the global production of chemicals has increased many times over. According to a comprehensive analysis of national and regional chemical ...
High tumor copy number variations burden was associated with poor prognosis in patients with endocrine-resistant breast cancer
High tumor copy number variations burden was associated with poor prognosis in patients with endocrine-resistant breast cancer
Abstract Background Several studies have showed alterations in genes were associated with endocrine resistance in breast cancer. Nevertheless, genomic characteristics in p...
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
PROGNOSTIC VALUE OF NT-PROBNP COMPLEMENTS THE GEACE SCORE IN PEOPLE WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME
Objectives This study was designed to investigate whether admission N-terminal pro-brain natriuretic peptide (NT-proBNP) increase the prognostic accuracy of Globa...
Chemicals without Harm
Chemicals without Harm
A proposal for a new chemicals strategy: that we work to develop safer alternatives to hazardous chemicals rather than focusing exclusively on controlling them. Toda...
Accelerated orphan drug approval: surrogate endpoints
Accelerated orphan drug approval: surrogate endpoints
Today, orphan drug development is confronted with significant challenges represented by the considerable complexity, diversity of clinical manifestations, and competition in study ...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Data from Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer
Data from Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer
<div>Abstract<p>Approximately one-third of endocrine-treated women with estrogen receptor alpha–positive (ER<sup>+</sup>) breast cancers are at risk of recu...

Back to Top